Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria

Table 3

Percentage of changes during 12 months in renal and metabolic outcomes between groups.

Percentage of changes with interquartile range	Sulodexide group; ()	Control group; ()	value between groups
BUN (mg/dL)	6.0 (-11.6 to 26.6)	12.7 (-4.0 to 33.9)	0.316
Creatinine (mg/dL)	15.8 (5.3 to 27.3)	12.3 (4.2 to 18.8)	0.198
GFR (mL/min/1.73 m^2)	-15.5 (-25.8 to -4.9)	-12.4 (-17.5 to -6.1)	0.201
Urine protein creatinine ratio (g/gCr)	-17.7 (-53.1 to 3.2)	19.4 (10.3 to 37.6)	0.001
Systolic blood pressure (mmHg)	-1.5 (-8.3 to 5.4)	4.5 (-1.8 to 10.5)	0.004
Diastolic blood pressure (mmHg)	0 (-8.2 to 6.8)	4.9 (-3.8 to 11.9)	0.077
Fasting plasma glucose (mg/dL)	0.8 (-13.9 to 10.9)	5.5 (-6.3 to 16.9)	0.241
Hemoglobin A1C (%)	-1.6 (-10.9 to 7.7)	1.5 (-2.6 to 6.8)	0.254

Data presents as percentage with interquartile range. BUN: blood urea nitrogen; GFR: glomerular filtration rate.